What one share of Greenwich Lifesciences holds
Greenwich Lifesciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.58 |
|---|---|
| Cash and investments | $0.60 |
| Book value | $0.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$1.52 | — | — | — | — |
| 2020 | — | −$0.20 | — | — | — | $2.18 |
| 2021 | — | −$0.35 | — | — | — | $2.04 |
| 2022 | — | −$0.61 | — | — | — | $1.03 |
| 2023 | — | −$0.69 | — | — | — | $0.52 |
| 2024 | — | −$1.34 | — | — | — | $0.07 |
| 2025 | — | −$1.43 | — | — | — | $0.02 |
Common questions about Greenwich Lifesciences
How much does one share of Greenwich Lifesciences earn?
Over the last 12 months, Greenwich Lifesciences lost $1.58 for each share.
Does Greenwich Lifesciences pay a dividend?
Greenwich Lifesciences didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Greenwich Lifesciences’s book value per share?
Greenwich Lifesciences’s book value is $0.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Greenwich Lifesciences have?
Each share of Greenwich Lifesciences has $0.60 of cash and investments, as of June 30, 2026.
Has Greenwich Lifesciences bought back shares?
Greenwich Lifesciences’s share count rose about 499% from 2019 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.